Literature DB >> 29959169

What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? 'Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus'.

Maud Lemoine1, Hans L Tillmann2,3.   

Abstract

Entities:  

Keywords:  Hcv; diagnostic virology

Mesh：

Substances：

Year:  2018        PMID： 29959169     DOI： 10.1136/gutjnl-2018-316438

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  In-field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania.

Authors:  Zameer Mohamed; Jessie Mbwambo; John Rwegasha; Nicodem Mgina; Basra Doulla; Promise Mwakale; Edouard Tuaillon; Stephane Chevaliez; Yusuke Shimakawa; Simon D Taylor-Robinson; Mark R Thursz; Ashley S Brown; Maud Lemoine
Journal:  Liver Int       Date:  2019-12-15       Impact factor: 8.754

2.  Diagnostic Performance and Usability of the Genedrive® HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia.

Authors:  Francois M J Lamoury; Richard Njouom; Marie Amougou-Atsama; Euloge Yiagnigni Mfopou; Nino Berishvili; Manana Sologashvili; Emmanuel Fajardo; Agnes Malobela; Aurélien Macé; Maxwell Chirehwa; Maia Alkhazashvili; Elena Ivanova Reipold
Journal:  Diagnostics (Basel)       Date:  2021-04-22

3.  Potential utility of the Genedrive point-of-care test for HCV RNA detection.

Authors:  Alba Llibre; Yusuke Shimakawa; Darragh Duffy
Journal:  Gut       Date:  2018-09-22       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.